Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 11/20 | 0.85 |
| ▸ | AKR1B10 | O60218 | 5/20 | 0.85 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.85 |
| ▸ | TTR | P02766 | 4/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.85 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.85 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.85 |
| ▸ | MEN1 | O00255 | 1/20 | 0.85 |
| ▸ | GMNN | O75496 | 1/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.85 |
| ▸ | EGFR | P00533 | 1/20 | 0.85 |
| ▸ | LMNA | P02545 | 1/20 | 0.85 |
| ▸ | ESR1 | P03372 | 1/20 | 0.85 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.85 |
| ▸ | LCK | P06239 | 1/20 | 0.85 |
| ▸ | FYN | P06241 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20604716 | 0.96 | APP (0.83) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| SCHEMBL19359013 | 0.95 | APP (0.81) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| SCHEMBL19369291 | 0.95 | APP (0.81) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| SCHEMBL20914979 | 0.95 | APP (0.81) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| SCHEMBL20604718 | 0.95 | APP (0.81) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL30070826 | 0.92 | AKR1B10 (1.00) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL93649 | 0.92 | AKR1B10 (1.00) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL28294426 | 0.92 | AKR1B10 (1.00) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL490546 | 0.92 | AKR1B10 (1.00) | APPAKR1B10AKR1B1TTRCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL30695557 | 0.91 | TTR (0.97) | APPAKR1B10AKR1B1TTRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605352-B2 | Compositions and methods for inhibiting blood cancer cell growth | THE UNIVERSITY OF NEW BRUNSWICK (CA) | 2026-04-21 | — | — | US | claimed |
| US-20240425441-A9 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | ICOSA PHARMA INC. (CA) | 2024-12-26 | — | — | US | claimed |
| US-20230391711-A1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIV DE MONCTON (CA) | 2023-12-07 | — | — | US | claimed |
| EP-3423429-B1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIV DE MONCTON (CA) | 2023-07-12 | — | — | EP | claimed |
| US-20220211653-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH | THE UNIVERSITY OF NEW BRUNSWICK (CA) | 2022-07-07 | — | — | US | claimed |
| EP-3955911-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH | University of New Brunswick (CA) | 2022-02-23 | — | — | EP | claimed |
| WO-2020210920-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH | UNIVERSITY OF NEW BRUNSWICK (CA) | 2020-10-22 | — | — | WO | claimed |
| US-20190119194-A1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIVERSITE DE MONCTON (CA) | 2019-04-25 | — | — | US | claimed |
| US-12605352-B2 | Compositions and methods for inhibiting blood cancer cell growth | THE UNIVERSITY OF NEW BRUNSWICK (CA) | 2026-04-21 | — | — | US | disclosed |
| US-12605352-B2 | Compositions and methods for inhibiting blood cancer cell growth | THE UNIVERSITY OF NEW BRUNSWICK (CA) | 2026-04-21 | — | — | US | disclosed |
| US-20240425441-A9 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | ICOSA PHARMA INC. (CA) | 2024-12-26 | — | — | US | disclosed |
| US-20230391711-A1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIV DE MONCTON (CA) | 2023-12-07 | — | — | US | disclosed |
| EP-4276089-A2 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | Universite De Moncton (CA) | 2023-11-15 | — | — | EP | disclosed |
| EP-4276089-A2 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | Universite De Moncton (CA) | 2023-11-15 | — | — | EP | disclosed |
| US-20120129931-A1 | CAFFEIC ACID DERIVATIVES AND THEIR USE IN IMPROVING NEURONAL CELL VIABILITY | Chemigen (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120100122-A1 | COMBINATION THERAPY | Chemigen (US) | 2012-04-26 | — | — | US | disclosed |
| US-20120100122-A1 | COMBINATION THERAPY | Chemigen (US) | 2012-04-26 | — | — | US | disclosed |
| WO-2012054446-A2 | COMBINATION THERAPY | Chemigen (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20080167277-A1 | METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS | MOLECULIN, L.L.C. | 2008-07-10 | — | — | US | disclosed |
| US-20080167277-A1 | METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS | MOLECULIN, L.L.C. | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211653-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH | MCL1, BCL9, HCLS1 | APP 4643/4885AKR1B10 3265/4885AKR1B1 4104/4885 |
| US-20080167277-A1 | METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS | CYP24A1, VDR, CYP2R1 | APP 1238/4885AKR1B10 2192/4885AKR1B1 1890/4885 |
| US-20240425441-A9 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | ALOX12, ALOX15B, ALOX5 | APP 3143/4885AKR1B10 392/4885AKR1B1 182/4885 |
| US-20190119194-A1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | ALOX12, ALOX15B, ALOX5 | APP 3143/4885AKR1B10 392/4885AKR1B1 182/4885 |
| US-20230391711-A1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | ALOX12, ALOX15B, ALOX5 | APP 3143/4885AKR1B10 392/4885AKR1B1 182/4885 |
| US-20120129931-A1 | CAFFEIC ACID DERIVATIVES AND THEIR USE IN IMPROVING NEURONAL CELL VIABILITY | CCAR2, BDNF, CASP3 | APP 1097/4885AKR1B10 4586/4885AKR1B1 4466/4885 |
| US-12605352-B2 | Compositions and methods for inhibiting blood cancer cell growth | MCL1, HRH2, SLC25A11 | APP 4725/4885AKR1B10 2410/4885AKR1B1 2335/4885 |
| US-20120100122-A1 | COMBINATION THERAPY | SLC25A20, TFAM, NDUFAB1 | APP 551/4885AKR1B10 1036/4885AKR1B1 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.